Sarah Smith

Sarah Smith

Expertise: ESG Investing, Electric Vehicle Stocks, Short Squeeze Stocks

Education: BA, Government and Gender, Sexuality and Women’s Studies, The College of William & Mary

Awards & Accomplishments: Top 5% of stock pickers on TipRanks

About Sarah:
Sarah Smith is an experienced editor and writer who works to help retail investors make sense of what’s happening every day on Wall Street, and she’s particularly interested in ESG investing, EV stocks, and the rise of speculative trading activity like short squeezes. She has also written for Kiplinger.com, Smithsonian, and Washington City Paper. Sarah is currently working to become a Chartered Financial Analyst (CFA) and has already earned bachelor’s degrees in Government and Gender, Sexuality and Women’s Studies from the College of William and Mary. Her work for InvestorPlace.com focuses on helping investors understand the causes and impacts of daily stock and crypto market movements, and how a disruption in who invests – and how they invest – transforms the market. Sarah is recognized among the top 5% of stock pickers on TipRanks and has an average return of 50%. She lives in Arlington, Virginia.

Connect with Sarah on LinkedIn.

Recent Articles

CIIC Stock: Analyst Call Sends Shares Soaring Ahead of Arrival SPAC Merger

CIIC stock is once again climbing higher ahead of the Arrival SPAC merger. This time, credit goes to TV analyst Jim Cramer.

AMC Stock: Why AMC Entertainment Shares Sunk 16% Today

AMC stock and its movie theater peers sunk Thursday on news WarnerMedia was shaking up its movie release plans for 2021.

Flutter Entertainment News: 12 Things to Know About PDYPY Stock and the FanDuel Deal

PDYPY stock was climbing Thursday on news that Flutter Entertainment now has a 95% stake in online gambling firm FanDuel.

LMND Stock: Why Lemonade Shares Are Soaring 20% Today

LMND stock is soaring big thanks to a recommendation by The Motley Fool. Here's what else you need to know about Lemonade.

KNTE Stock: 13 Things to Know About the Kinnate Biopharma IPO

KNTE stock has rocketed higher by as much as 115% following the Kinnate Biopharma IPO. Here's what you should know right now.